In the CGGA cohort, BARD1, CBX3, CTSS, IFRD1, and STAT1 were similarly shown to have high accuracy in differentiating GBM samples from NG, A, and OD samples (Additional file 3: Figure S2). The gene discussed is BARD1; the disease is glioblastoma.